drugset / Trial / NCT06595706
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
NaSequentialTriple-blindTreatment
Summary
This study aims to determine the safety and pharmacokinetics of multiple ascending doses of Lucid-21-302 in healthy adult participants.
Timeline
- Start
- 2024-09-28
- Primary completion
- 2025-01-24
- Completion
- 2025-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lucid-21-302 | Small molecule | — | — |
Indications
No indication recorded.